Precision Regenerative Medicine Manufacturing with AI | Matthias Wagner

At the Precision Health Summit 2024, Matthias Wagner, Co-Founder and CTO of Cellino, presents a transformative approach to regenerative medicine manufacturing using AI. He addresses the scalability challenges of autologous cell therapies, which, despite their promise, are hindered by costly, manual production processes. Wagner introduces a closed-loop control system powered by AI and precision laser technology to automate cell culture management. This innovation enhances quality control, reduces costs, and aims to scale production from hundreds to millions of patients. Despite challenges in interdisciplinary integration and the need for standardization, Wagner's approach represents a paradigm shift toward making regenerative therapies widely accessible.